🇺🇸 AMGN — Amgen Inc.

Healthcare Compra
← Volver

Precio actual

437,23 USD

Máx. histórico

447,03

10 días

Caída desde máximo

-2,19%

Rango 52 semanas

269,77 – 447,03

Variación hoy

-1,55%

Cierre anterior

444,12

Rango de hoy

435,01 – 441,66

Volumen hoy

1.615.172

Información
Nombre completo
Amgen Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Healthcare
Industria
Drug Manufacturers - General
Empleados
31.500
PER
27,17 (puede no estar actualizado)
Dividend yield
2,27% (puede no estar actualizado)
Precio objetivo analistas
389,69 USD (puede no estar actualizado)
Primera cotización
17/06/1983
Precio actualizado
hace 2 días
Sobre la empresa

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel for the treatment of rheumatoid arthritis, plaque psoriasis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Prolia to treat postmenopausal women with osteoporosis; XGEVA for skeletal-related events prevention; Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization; Nplate for the treatment of patients with immune thrombocytopenia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; Aranesp to treat a lower-than-normal number of red blood cells and anemia; EVENITY for the treatment of osteoporosis in postmenopausal for women; Vectibix to treat patients with wild-type RAS metastatic colorectal cancer; BLINCYTO for the treatment of patients with acute lymphoblastic leukemia; TEPEZZA to treat thyroid eye disease; and KRYSTEXXA for the treatment of chronic refractory gout. It also markets other products, including PROLIA, REPATHA, OTEZLA, ENBREL, EVENITY, XGEVA, TEPEZZA, BLINCYTO, NPLATE, TEZSPIRE, KYPROLIS, ARANESP, KRYSTEXXA AND VECTIBIX, MVASI, PAVBLU, UPLIZNA, IMDELLTRA/IMDYLLTRA, AMJEVITA/AMGEVITA, TAVNEOS, NEULASTA, LUMAKRAS/LUMYKRAS, RAVICTI, PARSABIV, AIMOVIG, WEZLANA/WEZENLA, AND PROCYSBI. The company serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors. The company has collaboration agreements with AstraZeneca plc for the development and commercialization of TEZSPIRE; BEONE MEDICINES LTD. to develop and commercialize Aimovig; UCB for the development and commercialization of EVENITY; Kyowa Kirin Co., Ltd. for rocatinlimab development and commercialization; and BeiGene, Ltd. for oncology products expansion and development. The company was incorporated in 1980 and is headquartered in Thousand Oaks, California.

Dividendos repartidos Total últimos 12 meses: 9,9400 USD · Yield: 2,27%
Fecha de pago Importe por participación
16/08/2011 0,2800 USD
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
24/07/2018 191,25 193,20 190,50 191,40 +0,75% 1,41% 2.440.400
23/07/2018 190,11 190,97 189,16 189,97 -0,27% 0,95% 1.767.000
20/07/2018 191,48 191,48 189,49 190,49 -0,66% 1,04% 2.252.200
19/07/2018 191,86 192,85 190,29 191,76 -0,54% 1,33% 2.539.200
18/07/2018 193,25 194,00 192,05 192,80 -0,58% 1,01% 2.215.800
17/07/2018 192,37 194,90 192,11 193,92 -0,49% 1,45% 2.567.300
16/07/2018 195,71 196,57 194,11 194,88 -0,53% 1,26% 1.824.800
13/07/2018 194,99 196,75 193,38 195,91 +0,94% 1,73% 2.232.000
12/07/2018 194,19 194,26 192,56 194,08 +0,48% 0,88% 2.251.900
11/07/2018 194,60 195,19 192,52 193,15 -1,30% 1,37% 2.431.400
10/07/2018 194,17 196,15 192,54 195,69 +0,78% 1,86% 2.757.000
09/07/2018 191,50 194,39 191,17 194,17 +1,65% 1,68% 3.065.500
06/07/2018 188,57 191,49 188,01 191,01 +1,95% 1,85% 2.751.600
05/07/2018 186,14 188,17 185,61 187,36 +0,89% 1,38% 1.801.000
03/07/2018 186,45 187,40 185,57 185,71 +0,23% 0,98% 1.348.000
02/07/2018 184,09 185,46 182,70 185,29 +0,38% 1,50% 2.069.800
29/06/2018 183,59 186,05 183,59 184,59 +0,68% 1,34% 2.606.200
28/06/2018 183,16 184,58 181,70 183,34 -0,10% 1,57% 2.286.300
27/06/2018 184,92 187,36 183,47 183,53 -0,57% 2,10% 2.354.800
26/06/2018 185,34 185,95 183,98 184,59 -0,42% 1,06% 2.070.600
25/06/2018 185,01 186,69 184,07 185,36 +0,11% 1,42% 2.678.200
22/06/2018 186,31 188,09 184,83 185,15 -0,45% 1,75% 11.153.100
21/06/2018 186,51 186,51 184,42 185,99 -0,28% 1,12% 2.206.400
20/06/2018 186,25 187,51 184,74 186,51 +0,17% 1,49% 2.415.200
19/06/2018 182,83 186,34 182,83 186,19 +1,22% 1,92% 2.538.500
18/06/2018 184,13 184,50 182,38 183,95 -0,57% 1,15% 2.370.700
15/06/2018 186,47 186,74 184,02 185,01 -0,42% 1,46% 6.474.500
14/06/2018 184,09 186,07 182,70 185,79 +1,15% 1,83% 2.289.600
13/06/2018 185,36 186,57 183,45 183,68 -0,75% 1,68% 2.243.900
12/06/2018 184,27 185,12 183,41 185,07 +0,25% 0,93% 2.045.300